Cotinga Pharmaceuticals appoints Matt Bond to its Board of Directors and announces Victor Hugo as new CFO
– CANADA, London – Cotinga Pharmaceuticals Inc. (TSX-V:COT / OTCQB:COTQF), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced the appointment of Victor Hugo as Chief Financial Officer effective July 20, 2018, and the appointment of J.…